Your session is about to expire
← Back to Search
GUMMETAL vs Stainless Steel Wires for Misaligned Teeth
N/A
Waitlist Available
Research Sponsored by State University of New York at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Full permanent dentition (except third molars)
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
This trialinvestigates how well a new material (GUMMETAL) closes gaps between teeth compared to an industry standard (stainless steel). We think stainless steel is more efficient.
Who is the study for?
This trial is for individuals with misaligned teeth and gaps of at least 3 mm behind the upper canine teeth. Participants should have a normal to low facial bone growth pattern, any type of dental bite issues, good oral hygiene, overall health, and all permanent teeth (except wisdom teeth). Those with gum disease, significant tooth root damage or abnormal shapes/sizes of teeth, facial bone structure anomalies, high facial bone growth pattern, systemic diseases or syndromes or past braces treatment are excluded.Check my eligibility
What is being tested?
The study compares two types of orthodontic wires used in braces for closing spaces between teeth: a new wire called GUMMETAL and the traditional stainless steel wire. The efficiency in space closure will be measured to determine if GUMMETAL offers benefits over the standard option.See study design
What are the potential side effects?
While specific side effects aren't listed for this trial, generally orthodontic treatments can cause discomfort or pain from tooth movement, irritation inside the mouth from brackets and wires, and potential minor injury to gums or cheeks.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have all my permanent teeth, except for wisdom teeth.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Maxillary canine retraction rate between GUMMETAL and SS archwires
Secondary outcome measures
3-Dimensional control of canine movement assessment
Total amount of retraction in millimeters
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: GUMMETAL TiNbTaZrExperimental Treatment1 Intervention
TiNbTaZr (Beta-Titanium) Alloy used to manufacture orthodontic archwires. We will be using an archwire with the size of 0.016 x 0.022"
Group II: Stainless Steel (CrNi)Active Control1 Intervention
Stainless steel (18% Chromium and 8% Nickel) used as the control, and linked anteriorly to the GUMMETAL counterpart. Size of archwire is 0.016 x 0.022"
Find a Location
Who is running the clinical trial?
State University of New York at BuffaloLead Sponsor
246 Previous Clinical Trials
49,496 Total Patients Enrolled
2 Trials studying Malocclusion
17 Patients Enrolled for Malocclusion
Thikriat Al-JewairStudy ChairUniversity at Buffalo
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a problem with the way your teeth fit together.I have all my permanent teeth, except for wisdom teeth.My tumor grows in many different directions.I have a condition that affects my whole body.I am in good overall health and have healthy teeth and gums.You have facial or skull abnormalities.I have severe gum disease affecting more than 25% of my tooth root.You have a growth pattern that is within the normal range or slightly lower.I maintain good oral hygiene.My teeth are abnormally sized or shaped.I have had braces or other orthodontic treatment before.I am taking anti-inflammatory medication.
Research Study Groups:
This trial has the following groups:- Group 1: GUMMETAL TiNbTaZr
- Group 2: Stainless Steel (CrNi)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger